Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Teva shares surge after announcing global opioid settlement
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva sells its only manufacturing plant in Russia
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva puts further $468m aside for opioid settlements | Financial Times
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Is A Fall Imminent For Teva Stock After Its Recent Rally? | Trefis
Will Teva Stock Rebound After A 10% Fall In A Month?
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
'Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Finds Relief In US Opioid Crisis Settlement, Updates Long-Term Objectives :: Scrip
